Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Acute Myeloid Leukemia(AML)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04069208
What this trial is testing

IA14 Induction in Young Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Peking Union Medical College Hospital 42
Large-scale testing (Phase 3)Study completedNCT00474006
What this trial is testing

High Dose Daunorubicin Vs. Standard Dose Daunorubicin in Induction Treatment of AML

Who this might be right for
ACUTE MYELOGENOUS LEUKEMIA
Cooperative Study Group A for Hematology 398
Early research (Phase 1)Study completedNCT01254578
What this trial is testing

Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11+39 more
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Ended earlyNCT06268574
What this trial is testing

Safety and Efficacy of RVU120 for Treatment of Relapsed/Refractory AML

Who this might be right for
Acute Myeloid Leukemia (AML)High-risk Myelodysplastic Syndrome
Ryvu Therapeutics SA 62
Testing effectiveness (Phase 2)Study completedNCT00096122
What this trial is testing

Idarubicin, Cytarabine, and Tipifarnib in Treating Patients With Newly Diagnosed Myelodysplastic Syndromes or Acute Myeloid Leukemia

Who this might be right for
Adult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+20 more
National Cancer Institute (NCI) 95
Testing effectiveness (Phase 2)Study completedNCT01904136
What this trial is testing

Natural Killer Cells Before and After Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAcute Myeloid Leukemia With Gene Mutations+6 more
M.D. Anderson Cancer Center 54
Testing effectiveness (Phase 2)Study completedNCT00932412
What this trial is testing

The CLARA Study From the Acute Leukemia French Association (ALFA 0702 Trial)

Who this might be right for
Acute Myeloid Leukemia
Hospices Civils de Lyon 735
Large-scale testing (Phase 3)UnknownNCT06182592
What this trial is testing

A Bridging Study of Liposomal Cytarabine-Daunorubicin in Treating Olderly Patients With Treatment-naive High-Risk (Secondary) Acute Myeloid Leukemia

Who this might be right for
High-risk (Secondary) Acute Myeloid Leukemia
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 120
Testing effectiveness (Phase 2)Study completedNCT00083187
What this trial is testing

VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Vion Pharmaceuticals 230
Testing effectiveness (Phase 2)Study completedNCT00002833
What this trial is testing

Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes
M.D. Anderson Cancer Center 53
Early research (Phase 1)Study completedNCT04901416
What this trial is testing

Safety and Efficacy of Allogeneic NK Cell Infusions in Patients With Relapsed/Refractory AML and High Risk MDS

Who this might be right for
AML, Adult RecurrentMDS
Coeptis Therapeutics 8
Early research (Phase 1)Study completedNCT00401739
What this trial is testing

Safety, Tolerability and Pharmacokinetics of CSL360 in the Treatment of Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)
CSL Limited 40
Early research (Phase 1)Looking for participantsNCT06146257
What this trial is testing

GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
GluBio Therapeutics Inc. 48
Testing effectiveness (Phase 2)WithdrawnNCT06337331
What this trial is testing

Adding Venetoclax to the High-dose Chemotherapy Regimen Prior to Mismatche Allogeneic Stem Cell Transplant

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
Northside Hospital, Inc.
Early research (Phase 1)Looking for participantsNCT02508038
What this trial is testing

Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaHodgkin Lymphoma+8 more
University of Wisconsin, Madison 22
Testing effectiveness (Phase 2)Looking for participantsNCT06262438
What this trial is testing

CHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients

Who this might be right for
Acute Myeloid Leukemia in Children
Princess Maxima Center for Pediatric Oncology 60
Testing effectiveness (Phase 2)UnknownNCT04749355
What this trial is testing

Phase 2, Open-Label, Single Arm Study, With BST-236 in Adults With R/R AML or Higher-Risk MDS

Who this might be right for
AML, AdultMDSRelapse/Recurrence+1 more
BioSight Ltd. 40
Testing effectiveness (Phase 2)Looking for participantsNCT07591649
What this trial is testing

Adapt NK for High Risk Myeloid Diseases as Bridge to Allo HSCT

Who this might be right for
Relapsed Adult AMLRefractory AMLAcute Myelogenous Leukemia
Masonic Cancer Center, University of Minnesota 18
Testing effectiveness (Phase 2)Study completedNCT00003396
What this trial is testing

Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of Maryland, Baltimore 42
Testing effectiveness (Phase 2)Ended earlyNCT02302846
What this trial is testing

Study of MLN9708 as Maintenance Therapy for Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS) in Remission

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 5
Next Page